Abstract
Endometriosis is a condition that affects women of reproductive age, and it is distinguished by the development of endometrial-like tissue outside the uterine cavity. It is frequently accompanied by persistent pelvic discomfort and infertility. This investigation looks into recent findings on clinical manifestation to help doctors and improve women's health. PubMed and Google Scholar were used to review on clinical diagnosis of endometriosis. The search strategy contained the terms “endometriosis” and “clinical diagnosis.” All research articles published between 1960 and 2021 were included in the search. The findings were then categorized to summarize the evidence. There was a total of 29 instances of endometriosis discovered. The patients' ages varied from 20 to 45 years old, with a median of 28.8 years and a mean of 29.4±7.7 years. Dysmenorrhea is a common disorder among adolescent girls experiencing various physical and emotional symptoms which have a detrimental influence on their quality of life. In this study, scar endometriosis was shown to be the more common variety of endometriosis, with 50% of cases predominantly developing at the lower segment cesarean section (LSCS) scar site. As a result, women with endometriosis are more likely to have miscarriages, and the quality of their embryos declines as a result.
Keywords: infertility, endometrial, uterus, scar, endometriosis
Introduction and background
Endometriosis is the most perplexing gynecological condition [1-3]. Endometriosis influences 10%-15% of all reproductive-age females and 70% of women with persistent pelvic pain [4]. The ovaries and pelvic peritoneum are the most common sites for developing endometriotic lesions. Endometriotic lesions can also develop in other places including the fallopian tube, abdominal wall, bowels, cervix, bladder, and vagina [5,6]. The pathophysiology of endometriosis and pain is poorly known, with most gynecologists believing that inflammation is a crucial source of irritation in endometriosis [7]. After successful surgery, some women seem to be “cured” of the disorder, but the majority will have a recurrence of symptoms. Endometriosis costs roughly 1 to 2 lakhs per woman in India, according to a survey [8]. The uterosacral ligaments, the upper third part of the posterior vaginal wall, the rectovaginal space, the intestine, and the urinary system are frequently involved in the latter [9]. Researchers have previously looked at apoptosis, cell cycle changes, and granulosa cell oxidative stress as indicators of oocyte quality as a source of endometriosis subfertility [10-12].
Endometriosis is a female reproductive system disorder where the endometrium-like tissue develops outside of the uterus; it usually affects the ovaries and peritoneum, causing premenstrual discomfort and dysmenorrhea [13,14]. The most widely recognized explanation of endometriosis is that endometrial tissue is implanted in the peritoneal cavity by retrograde menstruation. The first theory describing the origin of endometriosis is the retrograde menstruation theory. According to this idea, endometriosis develops when sloughed endometrial cells and debris after menstruation travel retrogradely down the fallopian tubes and enter the pelvic cavity. 76%-90% of women having patent fallopian tubes experience retrograde menstruation, albeit not all of these women have endometriosis [15]. Endometrial cell resorption into the abdominal wall during menstrual flow is a common occurrence in 90% of menstrual females with patent fallopian tubes, even though it is only seen in those with hormonal or immunological issues [16,17]. The peritoneal fluid of women with endometriosis has higher amounts of macrophages, T-lymphocytes, and B-lymphocytes, which are more susceptible to apoptosis [18,19].
Review
Clinical diagnosis of endometriosis
Endometriosis lesions are most frequently encountered in the following regions like fallopian tubes, uterus outer surface, ovaries, and the ligaments which surround the uterus. Lesions from endometriosis can range in size and frequently take the form of nodules or cysts. The majority of them are blue, black, and brown in color. They can, however, sometimes occasionally be white, red, or transparent [20,21]. Infertile women with minor or mild endometriosis have had the condition detected more frequently during in vitro fertilization (IVF) and embryo transfer (ET) cycles than those with moderate or severe endometriosis [1,22-24]. With a diagnostic age of 28 years, endometriosis predominantly affects women who are of reproductive age, which may be understood by the estrogenic milieu, which is strongly implicated in its genesis [25]. Extrauterine endometrial cells on laparoscopy are generally enough for histologic confirmation [26]. Cystic endometriomas might be reliably recognized utilizing transvaginal ultrasonography, while more modest endometrial implants are not detected [27,28].
Infertility and severe pelvic discomfort are the two major clinical risk factors for endometriosis [29-32]. The etiology of infertility in women with minor or mild endometriosis is less understood. However, it might be linked to a greater prevalence of malformed oocytes, faulty embryos, or unsuccessful implantation [33]. According to several studies, tall women with low Body Mass Index (BMI) appear at a greater risk of developing endometriosis because they have short menstrual cycles, are more likely to have cervical canalization problems, and decreased germ cell endowment [34]. Endometriosis has also been found to be less common among women who have been pregnant [29]. This might be owing to pregnancy's protective impact, or it could be due to endometriosis patients' lower fertility, as endometriosis risk is inversely associated with the number of term pregnancies [29,35,36].
Endometriosis was found in 19% of women with persistent pelvic discomfort at the point of surgery [37,38]. Dysmenorrhea, intermenstrual discomfort, and dyspareunia are common symptoms of pelvic pain. The most prevalent symptom is dysmenorrhea, which, while not predictive, is highly indicative of endometriosis in its severe form [39]. Dysmenorrhea is frequently progressive, with discomfort beginning before menstrual flow and lasting for the whole of the menstrual cycle and possibly for many days after that [40,41]. Endometriosis of the rectovaginal septum and cul-de-sac are common causes of dyspareunia [42]. Dysmenorrhea and dyspareunia are more likely to be caused by endometriosis if they appear after years of pain-free menses and coitus [43,44]. The overproduction of uterine prostaglandins aids pathogenesis. Urinary tract endometriosis can induce hematuria, urgency, dysuria, and frequency [45,46].
Dysmenorrhea
During menstruation, dysmenorrhea is a medical disorder characterized by discomfort around the pubic bone and lower abdomen [47,48]. Dysmenorrhea is related to a limitation of activity and leaves from school or work, precisely when it is severe [49]. Mental preparedness and suitable lifestyle changes, such as frequent physical activity, can help control dysmenorrhea [50]. Dysmenorrhea can be primary or secondary. Primary dysmenorrhea is a kind of dysmenorrhea that occurs in teenagers shortly after menarche and is caused by a lack of underlying macroscopic pelvic disease [51]. Early menarche, lengthier menstrual cycles, high menstrual flow, and a family history of dysmenorrhea are all risk factors [52,53].
Dyspareunia
Dyspareunia, or pain during penetration, occurs during sexual activity. Deep and superficial dyspareunia are the two most common kinds of dyspareunia [54]. Deep dyspareunia refers to the expansion of discomfort into the deeper regions of the vagina or lower pelvis, whereas superficial dyspareunia is restricted to the vulva or vaginal entrance. Profound penetration is typically correlated with deep dyspareunia [55]. Deep dyspareunia in endometriosis has a complicated etiology that might involve direct endometriotic lesions, concomitant diagnosis, and other factors [56]. Deep dyspareunia affects 50% of all female patients, a disorder that affects 10% of reproductive-age females and is linked to the poor sexual quality of life. Other forms of pelvic pain, psychiatric comorbidities, and concomitant pain diagnoses can occur in women with endometriosis [55,57].
Pathogenesis of endometriosis
Endometriosis pathogenesis suggests that the disease's etiology is complicated and multifaceted, involving genetic, hormonal, immunological, and environmental factors [58]. The pathogenesis of superficial endometriosis and the genetic factors that prevent ectopic lesions from being removed and allow for peritoneal remodeling may both be triggered by retrograde menstruation. These are critical for endometriosis lesion growth [59]. Endometriosis is spread by a change in the peritoneal fluid composition due to biological, hormone, and environmental factors [60,61]. Deep nodule tumors that are not generally eliminated during menstruation, might be quickly produced in a baboon model by transplanting basal endometrial tissue [62,63]. Endometriosis progresses due to genetic changes that damage the cell, since females with endometriosis have an abnormal endometrial cellular response, favoring extrauterine adhesion and proliferation [64]. Endometriosis has a genetic inheritance pattern that is believed to include numerous loci, as well as some chromosomal areas that have been linked to the endometriosis phenotype [65]. Genetic factors, both inherited and acquired, might predispose females to the adherence of abnormal endometrial tissues to the peritoneal epithelium as well as the resistance of immune clearing of these lesions [66]. Endometrial fragments that are still viable are pushed into the fallopian tubes by a pressure gradient caused by dyssynergic uterine contractions [67,68]. They can implant, develop, and infiltrate pelvic bones when they enter the peritoneal cavity [69,70]. Hyperalgesia is a symptom of nerve pain, which is generally caused by nerve damage or inflammatory stimulation. Endometriotic stroma cells typically invade sensory nerve fibers in deep endometriosis [71,72].
Table 1. Stages of endometriosis.
Stage | Description |
I | Isolated implants characterize this minimal disease. There is no adhesions present. |
II | The peritoneum and ovaries are covered in superficial implants, which are a mild form of the disease. There were no significant adhesions seen. |
III | Multiple implants, both superficial and highly intrusive, make up the modern disease. Adhesions on the ovaries and fallopian tubes are possible. |
IV | Severe sickness is defined by several deep and superficial implants, massive ovarian endometriomas, and other symptoms. Typically, dense adhesions are present. |
Methods
We focused on pelvic endometriosis in this study since it is the most prevalent kind of endometriosis, and it usually affects women throughout their reproductive years. PubMed and Google Scholar were used to conduct a review of the clinical diagnosis of endometriosis. In the titles or abstracts of papers, the search strategy contained the terms “endometriosis” and “clinical diagnosis.” The data from each clinical diagnosis document were extracted and categorized.
Result
In this study, there were 29 cases of endometriosis in total. The age range of the patients was 20 to 45 years, with a mean age of 29.4±7.7 and a median age of 28.8 years. The scar endometriosis (16 cases) involving the anterior abdominal wall at the lower segment cesarean section (LSCS) scar site, ovarian endometriosis (10 cases), urinary bladder endometriosis (two cases), and bowel endometriosis (one case) involving the sigmoid colon. According to the data, ovarian endometriosis and scar endometriosis are the two types of endometriosis that are most common in women aged 20 to 35. Scar endometriosis has been the most frequent kind of endometriosis in this research, accounting for 50% of all cases. In 14 of the 16 patients, there was a mass in the LSCS scar, which was identified by preoperative Fine Needle Aspiration Cytology (FNAC) in nine instances (56.25%) and histological analysis of excised tissues in seven cases (43.75%). The second most prevalent condition was ovarian endometriosis, which accounted for 37.5% of cases, with one instance being bilateral and another showing torsion. Bowel endometriosis with only one case involving the sigmoid colon accounted for 4.3% of cases, whereas two cases with urinary bladder endometriosis accounted for 8.3%.
Treatment of endometriosis
The goal of medical therapy for endometriosis has been to change the menstrual period hormonally to induce a pseudopregnancy, pseudo-menopause, or persistent anovulatory state [73]. The recommended daily dose of danazol for the treatment of endometriosis is 600-800 mg; even so, the dose has significant steroid side effects, including increased hair growth, changes in mood, an irreversible deepening of the voice, bad impacts on serum lipids, and, in rare cases, irreversible and life-threatening liver injury [74]. Endometriosis is typically treated with progesterone-based medications. They induce endometrial cells to decidualize, resulting in atrophy. Abnormal uterine bleeding, vomiting, breast discomfort, and depression are all possible side effects [75,76]. Hypoestrogenism's adverse effects include vaginal heavy bleeding, vaginal dryness, reduced libido, breast discomfort, sleeplessness, and depression [77]. Endometriosis has been treated with a variety of hormones and medicines. Hormone therapy often prevents ovulation by preventing the ovaries from releasing hormones, including estrogen. This could aid in reducing the rate of local development and activity of the endometrium and endometrial lesions. Because of their negative side effects, several hormones, such as methyltestosterone and estrogen, have been phased out. Other medications have been inadequately investigated, including clomiphene, tamoxifen, and the anti-progestational drug mifepristone [78]. Laparoscopic surgery is used to surgically diagnose endometriosis. A laparoscope, a narrow viewing tube, is inserted into the belly through a tiny incision during laparoscopy. For a second entrance for the surgical tools, a second incision may be created in the lower abdomen. Your doctor can view the outside of the ovaries, uterus, fallopian tubes, and other organs up close using a laparoscope. Surgical tools for removing scar tissue or obtaining tissue samples can also be attached to the laparoscope [79]. For ovarian cysts greater than 4 to 5 cm in diameter, laparoscopic endometrioma removal is suggested [80]. Endometriosis has been treated with a range of devices, from monopolar cautery and scissors to a wide variety of lasers and ultrasonic scalpels [81]. Endometriosis pain is treated surgically by interrupting the brain circuits that carry pain signals [82]. Various considerations should be taken, including the best method of gaining access to the pelvis and abdomen, which can be accomplished by laparoscopy or laparotomy. Laparoscopy is less expensive and takes less time to recuperate. Magnetic resonance imaging (MRI) scan not only shows morphologic defects in the bladder but can also identify other common areas, such as the uterosacral joints, where ultrasonography is less accurate [83].
Discussion
Endometriosis affects people and cultures all over the world; however, there are significant delays in diagnosis. More illness awareness in inpatient healthcare should result in earlier diagnosis, less suffering, and increased productivity [84,85]. Gravidity, endometriosis in the family, dyspareunia, tiredness, dysmenorrhea, pelvic surgery, diarrhea, pelvic discomfort, and premenstrual spotting are all risk factors for endometriosis [86]. Several explanations for the connection between endometriosis and infertility have been claimed, but despite substantial investigation, no conclusion has been achieved. These mechanisms include distorted pelvic anatomy, altered peritoneal function, endocrine, and ovulatory abnormalities, and altered hormonal and cell-mediated functions in the endometrium [87,88]. Increased obstetric surgery results in the direct mechanical implantation of endometrial cells, which is one of the major risk factors for scar endometriosis [89].
When a patient experiences dysmenorrhea after experiencing pain-free menstrual cycles for years, endometriosis should be suspected [90]. Endometriomas having a maximal diameter of 3-4 cm are best treated through transvaginal cystectomy. Less than 1% of women develop ovarian endometriosis malignancy, which most frequently manifests as endometrioid/clear cell carcinoma [91]. Between 1% and 5% of women with endometriosis have urinary tract involvement, with the urinary bladder being the most commonly affected, followed by the ureter, urethra, and kidney [92,93]. In 3%-37% of instances, endometriosis was known to have an impact on the digestive system, with the recto-sigmoid colon as the most often affected area [94]. Although comparable findings have been documented in cancer patients, the link between diagnostic delay and health care funding for endometriosis is unique [95-97]. The majority of endometriosis patients have normal pelvic findings; hence a laparoscopy is required to make a conclusive diagnosis. It is likely that ultimately a combination of biochemical indicators and clinical evaluation will lessen the requirement for surgical confirmation, even if no single laboratory test has demonstrated proven clinical usefulness [98,99]. Endometriosis is more frequent among Caucasian, middle-aged, upper-class women who are ambitious. This could happen because these women have more access to medical treatment and diagnostic procedures like laparoscopy [100]. This might be because these women have easier access to medical treatment and diagnostic testing like laparoscopy [101,102]. As endometriosis frequently exhibits symptoms that resemble those of other disorders and cause a diagnostic delay, early suspicion of the condition is crucial for prompt diagnosis. In addition to a patient's medical history, secondary centers with access to further investigations may need to be referred from the main health care level [103,104].
Ovarian Endometriosis
Ovarian endometriomas account for 35% of all benign ovarian cysts and are seen in 17%-44% of female patients [105]. Endometrial cell growth may be induced by ovarian follicular fluid [106]. Left ovary endometriomas are more prevalent than right ovary endometriomas [107]. The amount of normal ovarian in the swollen ovarian cortex was decreased in endometrioma patients' ovarian cortical tissue, a result not seen in other benign cysts to a similar extent [108]. The ovary with endometrial cysts exhibits lower reactivity to exogenous gonadotropin activation, with more follicular atresia, and a higher rate of follicular atrophy [109]. The most prevalent histologic forms of ovarian cancer resulting from ovarian endometriosis are endometrioid adenocarcinoma and clear cell carcinoma [110,111].
Scar Endometriosis
Scar endometriosis occurs when endometrial tissue is implanted directly in scars during surgery [112]. Other surgical disorders such as hematoma, hernia, scar tissue, neuroma, abscess, granuloma, or even metastatic cancer can easily be coupled with scar endometriosis [113,114]. The presence of morphological and physiological stroma and endometrial gland beyond the uterine cavity is a persistent gynecologic condition [115]. The kidneys, pleura, bladder, lungs, colon, lymph nodes, omentum, and abdominal wall are all common locations for extra pelvic endometriosis [116].
Urinary Bladder Endometriosis
Extragenital endometriosis most commonly affects the gut and urinary system [117]. The urinary bladder is a rare location of endometrial localization, with just around 1% of people that are suffering from the illness having lesions affecting the urine system [118]. To avoid kidney function loss, urinary tract endometriosis must be diagnosed and treated early. For women who complain of bladder pain but have a negative urine test, the doctor may not examine if the discomfort is cyclic or whether bladder endometriosis is a possibility. Endometriosis in the urinary system is uncommon, occurring in about 1%-6% of females with initially diagnosed endometriosis [119].
Conclusions
Long-term conditions like endometriosis with symptoms like dyspareunia, dysmenorrhea, dysuria, dyschezia, and chronic pelvic pain (CPP) vary based on the organ affected, but not the illness itself. For early identification and management of bladder, ovarian, and intestine endometriosis, a higher index of concern is essential to improve the quality of life and decrease infertility. Dysmenorrhea is a fairly prevalent condition in adolescent girls, as they suffer from a variety of mental and physical symptoms that negatively impact their quality of life. Scar endometriosis has been the most common site of endometriosis in this research, with 50% of cases developing solely at the LSCS scar site. Minimal peritoneal endometriosis and also the most severe phases of the disease can be treated with laparoscopic surgery. Therefore, women with endometriosis are at a higher risk of miscarriage, and their embryo quality suffers.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
Footnotes
The authors have declared that no competing interests exist.
References
- 1.Oocyte quality is decreased in women with minimal or mild endometriosis. Xu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, Liu YS. Sci Rep. 2015;5:10779. doi: 10.1038/srep10779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Theories on the pathogenesis of endometriosis. Sourial S, Tempest N, Hapangama DK. Int J Reprod Med. 2014;2014:179515. doi: 10.1155/2014/179515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.The prognosis for live birth among untreated infertile couples. Collins JA, Burrows EA, Willan AR. Fertil Steril. 1995;64:22–28. [PubMed] [Google Scholar]
- 4.Endometriosis: epidemiology, diagnosis and clinical management. Parasar P, Ozcan P, Terry KL. Curr Obstet Gynecol Rep. 2017;6:34–41. doi: 10.1007/s13669-017-0187-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Farland L v, Shah DK, Kvaskoff M, et al. Cham: Springer; 2017. Epidemiological and clinical risk factors for endometriosis. . [Google Scholar]
- 6.Rich innervation of deep infiltrating endometriosis. Wang G, Tokushige N, Markham R, Fraser IS. Hum Reprod. 2009;24:827–834. doi: 10.1093/humrep/den464. [DOI] [PubMed] [Google Scholar]
- 7.Endometriosis: current and future medical therapies. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Best Pract Res Clin Obstet Gynaecol. 2008;22:275–306. doi: 10.1016/j.bpobgyn.2007.10.001. [DOI] [PubMed] [Google Scholar]
- 8.Impact of endometriosis on women's lives: a qualitative study. Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. BMC Womens Health. 2014;14:123. doi: 10.1186/1472-6874-14-123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Case study of a rare form of endometriosis. Cirstoiu M, Bodean O, Secara D, Munteanu O, Cirstoiu C. https://pubmed.ncbi.nlm.nih.gov/23599823/#:~:text=Deep%20infiltrative%20endometriosis%20(DIE)%20is,bowel%2C%20and%20the%20urinary%20tract. J Med Life. 2013;6:68–71. [PMC free article] [PubMed] [Google Scholar]
- 10.Is the oocyte quality affected by endometriosis? A review of the literature. Sanchez AM, Vanni VS, Bartiromo L, et al. J Ovarian Res. 2017;10:43. doi: 10.1186/s13048-017-0341-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes. Ohta N, Saito H, Kuzumaki T, et al. Mol Hum Reprod. 1999;5:22–28. doi: 10.1093/molehr/5.1.22. [DOI] [PubMed] [Google Scholar]
- 12.Ovarian fecundity in patients with endometriosis can be estimated by the incidence of apoptotic bodies. Nakahara K, Saito H, Saito T, et al. Fertil Steril. 1998;69:931–935. doi: 10.1016/s0015-0282(98)00038-7. [DOI] [PubMed] [Google Scholar]
- 13.Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. Eisenberg VH, Weil C, Chodick G, Shalev V. BJOG. 2018;125:55–62. doi: 10.1111/1471-0528.14711. [DOI] [PubMed] [Google Scholar]
- 14.Sexual function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety, and body image. Melis I, Litta P, Nappi L, et al. Int J Sexual Health. 2015;27:175–185. [Google Scholar]
- 15.Origins and progression of adolescent endometriosis. Brosens I, Gargett CE, Guo SW, Puttemans P, Gordts S, Brosens JJ, Benagiano G. Reprod Sci. 2016;23:1282–1288. doi: 10.1177/1933719116637919. [DOI] [PubMed] [Google Scholar]
- 16.Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Anaf V, Simon P, El Nakadi I, et al. Hum Reprod. 2000;15:1744–1750. doi: 10.1093/humrep/15.8.1744. [DOI] [PubMed] [Google Scholar]
- 17.Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2. Ballester M, Gonin J, Rodenas A, Bernaudin JF, Rouzier R, Coutant C, Daraï E. Hum Reprod. 2012;27:3179–3186. doi: 10.1093/humrep/des304. [DOI] [PubMed] [Google Scholar]
- 18.A prospective cohort study of endometriosis and subsequent risk of infertility. Prescott J, Farland LV, Tobias DK, et al. Hum Reprod. 2016;31:1475–1482. doi: 10.1093/humrep/dew085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Adolescent endometriosis: an update. Shim JY, Laufer MR. J Pediatr Adolesc Gynecol. 2020;33:112–119. doi: 10.1016/j.jpag.2019.11.011. [DOI] [PubMed] [Google Scholar]
- 20.Endometriosis and infertility: epidemiology and evidence-based treatments. Ozkan S, Murk W, Arici A. Ann N Y Acad Sci. 2008;1127:92–100. doi: 10.1196/annals.1434.007. [DOI] [PubMed] [Google Scholar]
- 21.The role of the new reproductive technologies including IVF and GIFT in endometriosis. Damewood MD. Obstet Gynecol Clin North Am. 1989;16:179–191. [PubMed] [Google Scholar]
- 22.The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. Harb HM, Gallos ID, Chu J, Harb M, Coomarasamy A. BJOG. 2013;120:1308–1320. doi: 10.1111/1471-0528.12366. [DOI] [PubMed] [Google Scholar]
- 23.Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Suzuki T, Izumi S, Matsubayashi H, Awaji H, Yoshikata K, Makino T. Fertil Steril. 2005;83:908–913. doi: 10.1016/j.fertnstert.2004.11.028. [DOI] [PubMed] [Google Scholar]
- 24.Effect of endometriosis on in vitro fertilization. Barnhart K, Dunsmoor-Su R, Coutifaris C. Fertil Steril. 2002;77:1148–1155. doi: 10.1016/s0015-0282(02)03112-6. [DOI] [PubMed] [Google Scholar]
- 25.An evidence-based evaluation of endometriosis-associated infertility. Pritts EA, Taylor RN. Endocrinol Metab Clin North Am. 2003;32:653–667. doi: 10.1016/s0889-8529(03)00045-8. [DOI] [PubMed] [Google Scholar]
- 26.Evaluation and treatment of endometriosis. Schrager S, Falleroni J, Edgoose J. https://pubmed.ncbi.nlm.nih.gov/23317074/ Am Fam Physician. 2013;87:107–113. [PubMed] [Google Scholar]
- 27.Clinical management of endometriosis. Luna Russo MA, Chalif JN, Falcone T. Minerva Ginecol. 2020;72:106–118. doi: 10.23736/S0026-4784.20.04544-X. [DOI] [PubMed] [Google Scholar]
- 28.The role of transvaginal ultrasonography combined with color velocity imaging and pulsed Doppler in the diagnosis of endometrioma. Alcázar JL, Laparte C, Jurado M, et al. Fertil Steril. 1997;67:487–491. doi: 10.1016/s0015-0282(97)80074-x. [DOI] [PubMed] [Google Scholar]
- 29.Diagnosis of endometriosis in the 21st century. Kiesel L, Sourouni M. Climacteric. 2019;22:296–302. doi: 10.1080/13697137.2019.1578743. [DOI] [PubMed] [Google Scholar]
- 30.Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Strathy JH, Molgaard CA, Coulam CB, et al. Fertil Steril. 1985;44:667–672. doi: 10.1016/s0015-0282(16)46691-4. [DOI] [PubMed] [Google Scholar]
- 31.Prevalence and genesis of endometriosis. Mahmood TA, Templeton A. Hum Reprod. 1991;6:544–549. doi: 10.1093/oxfordjournals.humrep.a137377. [DOI] [PubMed] [Google Scholar]
- 32.Laparoscopic evaluation of apparently normal infertile women. el-Yahia AW. Aust N Z J Obstet Gynaecol. 1994;34:440–442. doi: 10.1111/j.1479-828x.1994.tb01266.x. [DOI] [PubMed] [Google Scholar]
- 33.Clinical aspects of adolescent endometriosis. [ Oct; 2022 ];Nakamura T. Endocrines. 2021 2:301–310. [Google Scholar]
- 34.Epidemiologic determinants of endometriosis: a hospital-based case- control study. Signorello LB, Harlow BL, Cramer DW, et al. Ann Epidemiol. 1997;7:267–274. doi: 10.1016/s1047-2797(97)00017-3. [DOI] [PubMed] [Google Scholar]
- 35.Epidemiology of endometriosis among parous women. Sangi-Haghpeykar H, Poindexter AN. Obstet Gynecol. 1995;85:983–992. doi: 10.1016/0029-7844(95)00074-2. [DOI] [PubMed] [Google Scholar]
- 36.Risk factors for pelvic endometriosis in women with pelvic pain or infertility. Parazzini F, Ardovino I, Struzziero E, et al. Eur J Obstet Gynecol Reprod Biol. 1999;83:195–199. doi: 10.1016/s0301-2115(98)00332-7. [DOI] [PubMed] [Google Scholar]
- 37.Laparoscopy in 100 women with chronic pelvic pain. Kresch AJ, Seifer DB, Sachs LB, et al. Obstet Gynecol. 1984;64:672–674. [PubMed] [Google Scholar]
- 38.Clinical presentation and diagnosis of endometriosis. Galle PC. Obstet Gynecol Clin North Am. 1989;16:29–42. [PubMed] [Google Scholar]
- 39.Menstrual symptoms in women with pelvic endometriosis. Mahmood TA, Templeton AA, Thomson L, Fraser C. Br J Obstet Gynaecol. 1991;98:558–563. doi: 10.1111/j.1471-0528.1991.tb10370.x. [DOI] [PubMed] [Google Scholar]
- 40.Clinical characteristics of adolescent endometriosis. Davis GD, Thillet E, Lindemann J. J Adolesc Health. 1993;14:362–368. doi: 10.1016/s1054-139x(08)80008-0. [DOI] [PubMed] [Google Scholar]
- 41.Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain. Parazzini F, Cipriani S, Moroni S, et al. Hum Reprod. 2001;16:2668–2671. doi: 10.1093/humrep/16.12.2668. [DOI] [PubMed] [Google Scholar]
- 42.Endometriosis and pelvic pain: Relation to disease stage and localization. Vercellini P, Trespidi L, de Giorgi O, et al. Fertil Steril. 1996;65:299–304. [PubMed] [Google Scholar]
- 43.Pain symptoms associated with endometriosis. Fedele L, Bianchi S, Bocciolone L, Di Nola G, Parazzini F. https://pubmed.ncbi.nlm.nih.gov/1565363/ Obstet Gynecol. 1992;79:767–769. [PubMed] [Google Scholar]
- 44.Endometriosis. II. Emergency operations due to hemoperitoneum. Ranney B. https://pubmed.ncbi.nlm.nih.gov/5451140/ Obstet Gynecol. 1970;36:437–442. [PubMed] [Google Scholar]
- 45.Scar endometriosis. Brenner C, Wohlgemuth S. Surg Gynecol Obstet. 1990;170:538–540. [PubMed] [Google Scholar]
- 46.Renal and diaphragmatic endometriosis de novo associated with hormone replacement therapy. Chinegwundoh FI, Ryan P, Luesley T, Chan SY. J Urol. 1995;153:380–381. doi: 10.1097/00005392-199502000-00025. [DOI] [PubMed] [Google Scholar]
- 47.A case study of the prevalence of dysmenorrhea and its effects among females of different age groups. Olubunmi OP, Yinka OS, Oladele OJ, et al. J Exp Integr Med. 2016;6:125. [Google Scholar]
- 48.Studies on pre-modern medical history in Korea, 2010-2019: Increased study areas and diversified approaches. Kim SS. Uisahak. 2020;29:371–423. doi: 10.13081/kjmh.2020.29.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.The natural history of primary dysmenorrhoea: a longitudinal study. Weissman AM, Hartz AJ, Hansen MD, Johnson SR. BJOG. 2004;111:345–352. doi: 10.1111/j.1471-0528.2004.00090.x. [DOI] [PubMed] [Google Scholar]
- 50.A study of dysmenorrhea during menstruation in adolescent girls. Agarwal AK, Agarwal A. Indian J Community Med. 2010;35:159–164. doi: 10.4103/0970-0218.62586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Primary dysmenorrhea: evaluation and treatment pattern among female medical students. Gupta S, Kaur S, Sadiq S, et al. Int J Basic Clinic Pharmacol. 2018;7 [Google Scholar]
- 52.Influencing factors of dysmenorrhoea among hospital nurses: a questionnaire survey in Taiwan. Chiu MH, Hsieh HF, Yang YH, Chen HM, Hsu SC, Wang HH. BMJ Open. 2017;7:0. doi: 10.1136/bmjopen-2017-017615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Dawood MY. Drugs. 1981;22:42–56. doi: 10.2165/00003495-198122010-00003. [DOI] [PubMed] [Google Scholar]
- 54.Deep dyspareunia and sexual quality of life in women with endometriosis. Shum LK, Bedaiwy MA, Allaire C, et al. Sex Med. 2018;6:224–233. doi: 10.1016/j.esxm.2018.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Concurrent deep-superficial dyspareunia: prevalence, associations, and outcomes in a multidisciplinary vulvodynia program. Yong PJ, Sadownik L, Brotto LA. J Sex Med. 2015;12:219–227. doi: 10.1111/jsm.12729. [DOI] [PubMed] [Google Scholar]
- 56.Deep dyspareunia in endometriosis: a proposed framework based on pain mechanisms and genito-pelvic pain penetration disorder. Yong PJ. Sex Med Rev. 2017;5:495–507. doi: 10.1016/j.sxmr.2017.06.005. [DOI] [PubMed] [Google Scholar]
- 57.Impact of a multidisciplinary vulvodynia program on sexual functioning and dyspareunia. Brotto LA, Yong P, Smith KB, Sadownik LA. J Sex Med. 2015;12:238–247. doi: 10.1111/jsm.12718. [DOI] [PubMed] [Google Scholar]
- 58.Nap AW. Endometriosis: Science and Practice. England: Blackwell Publishing Ltd; 2012. Theories on the pathogenesis of endometriosis. [Google Scholar]
- 59.Involvement of resistance to apoptosis in the pathogenesis of endometriosis. Nasu K, Yuge A, Tsuno A, Nishida M, Narahara H. Histol Histopathol. 2009;24:1181–1192. doi: 10.14670/HH-24.1181. [DOI] [PubMed] [Google Scholar]
- 60.Expression of the fibrinolytic components in endometriosis. Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A. Pathophysiol Haemost Thromb. 2006;35:136–140. doi: 10.1159/000093556. [DOI] [PubMed] [Google Scholar]
- 61.Oxidative stress may be a piece in the endometriosis puzzle. Szczepańska M, Koźlik J, Skrzypczak J, et al. Fertil Steril. 2003;79:1288–1293. doi: 10.1016/s0015-0282(03)00266-8. [DOI] [PubMed] [Google Scholar]
- 62.Is the baboon model appropriate for endometriosis studies? Dehoux JP, Defrère S, Squifflet J, et al. Fertil Steril. 2011;96:728–733. doi: 10.1016/j.fertnstert.2011.06.037. [DOI] [PubMed] [Google Scholar]
- 63.Induction of endometriotic nodules in an experimental baboon model mimicking human deep nodular lesions. Donnez O, Van Langendonckt A, Defrère S, et al. Fertil Steril. 2013;99:783–789. doi: 10.1016/j.fertnstert.2012.10.032. [DOI] [PubMed] [Google Scholar]
- 64.Implantation versus infiltration: the Sampson versus the endometriotic disease theory. Koninckx PR, Barlow D, Kennedy S. Gynecol Obstet Invest. 1999;47 Suppl 1:3–10. doi: 10.1159/000052853. [DOI] [PubMed] [Google Scholar]
- 65.Genome-wide association study link novel loci to endometriosis. Albertsen HM, Chettier R, Farrington P, Ward K. PLoS One. 2013;8:0. doi: 10.1371/journal.pone.0058257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Pathogenesis and pathophysiology of endometriosis. Burney RO, Giudice LC. Fertil Steril. 2012;98:511–519. doi: 10.1016/j.fertnstert.2012.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Endometriomas are more frequent on the left side. Sznurkowski JJ, Emerich J. Acta Obstet Gynecol Scand. 2008;87:104–106. doi: 10.1080/00016340701671929. [DOI] [PubMed] [Google Scholar]
- 68.Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy. Parazzini F, Ferraroni M, Fedele L, Bocciolone L, Rubessa S, Riccardi A. J Epidemiol Community Health. 1995;49:61–64. doi: 10.1136/jech.49.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.The familial risk of endometriosis. Moen MH, Magnus P. Acta Obstet Gynecol Scand. 1993;72:560–564. doi: 10.3109/00016349309058164. [DOI] [PubMed] [Google Scholar]
- 70.Dysplastic nevi, cutaneous melanoma, and gynecologic disorders. Frisch RE, Wyshak G, Albert LS, Sober AJ. Int J Dermatol. 1992;31:331–335. doi: 10.1111/j.1365-4362.1992.tb03948.x. [DOI] [PubMed] [Google Scholar]
- 71.The relation of endometriosis to menstrual characteristics, smoking, and exercise. Cramer DW, Wilson E, Stillman RJ, et al. JAMA. 1986;255:1904–1908. [PubMed] [Google Scholar]
- 72.Preparedness of obstetrics and gynecology residents for fellowship training. Guntupalli SR, Doo DW, Guy M, et al. Obstet Gynecol. 2015;126:559–568. doi: 10.1097/AOG.0000000000000999. [DOI] [PubMed] [Google Scholar]
- 73.Tissue factors influencing growth and maintenance of endometriosis. Melega C, Balducci M, Bulletti C, Galassi A, Jasonni VM, Flamigni C. Ann N Y Acad Sci. 1991;622:256–265. doi: 10.1111/j.1749-6632.1991.tb37869.x. [DOI] [PubMed] [Google Scholar]
- 74.Interim report of a study of danazol for the treatment of endometriosis. Buttram VC, Belue JB, Reiter R. Fertil Steril. 1982;37:478–483. doi: 10.1016/s0015-0282(16)46151-0. [DOI] [PubMed] [Google Scholar]
- 75.Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Fertil Steril. 2007;88:789–794. doi: 10.1016/j.fertnstert.2006.12.077. [DOI] [PubMed] [Google Scholar]
- 76.Safety of medical treatments for endometriosis. Berlanda N, Somigliana E, Viganò P, Vercellini P. Expert Opin Drug Saf. 2016;15:21–30. doi: 10.1517/14740338.2016.1121991. [DOI] [PubMed] [Google Scholar]
- 77.Role of medical treatment of endometriosis. Martone S, Troìa L, Marcolongo P, Luisi S. Minerva Obstet Gynecol. 2021;73:304–316. doi: 10.23736/S2724-606X.21.04784-5. [DOI] [PubMed] [Google Scholar]
- 78.Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Balasch J, Creus M, Fábregues F, Carmona F, Martínez-Román S, Manau D, Vanrell JA. Hum Reprod. 1997;12:2046–2050. doi: 10.1093/humrep/12.9.2046. [DOI] [PubMed] [Google Scholar]
- 79.Surgical treatment of recurrent endometriosis: laparotomy versus laparoscopy. Busacca M, Fedele L, Bianchi S, Candiani M, Agnoli B, Raffaelli R, Vignali M. Hum Reprod. 1998;13:2271–2274. doi: 10.1093/humrep/13.8.2271. [DOI] [PubMed] [Google Scholar]
- 80.Laparoscopy versus microsurgery by laparotomy for excision of ovarian cysts in patients with moderate or severe endometriosis. Catalano GF, Marana R, Caruana P, et al. J Am Assoc Gynecol Laparosc. 1996;3:267–270. doi: 10.1016/s1074-3804(96)80011-9. [DOI] [PubMed] [Google Scholar]
- 81.Reproductive outcome after treatment of mild endometriosis with laparoscopic excision and electrocoagulation. Tulandi T, al-Took S. Fertil Steril. 1998;69:229–231. doi: 10.1016/s0015-0282(97)00469-x. [DOI] [PubMed] [Google Scholar]
- 82.Autonomic nervous system and inflammation interaction in endometriosis-associated pain. Wei Y, Liang Y, Lin H, Dai Y, Yao S. J Neuroinflammation. 2020;17:80. doi: 10.1186/s12974-020-01752-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Pre-operative assessment of bladder endometriosis. Fedele L, Bianchi S, Raffaelli R, Portuese A. Hum Reprod. 1997;12:2519–2522. doi: 10.1093/humrep/12.11.2519. [DOI] [PubMed] [Google Scholar]
- 84.World Endometriosis Society consensus on the classification of endometriosis. Johnson NP, Hummelshoj L, Adamson GD, et al. Hum Reprod. 2017;32:315–324. doi: 10.1093/humrep/dew293. [DOI] [PubMed] [Google Scholar]
- 85.A qualitative study of the impact of endometriosis on male partners. Culley L, Law C, Hudson N, Mitchell H, Denny E, Raine-Fenning N. Hum Reprod. 2017;32:1667–1673. doi: 10.1093/humrep/dex221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Evaluation of risk factors associated with endometriosis in infertile women. Ashrafi M, Sadatmahalleh SJ, Akhoond MR, et al. Int J Fertil Steril. 2016;10:11–21. doi: 10.22074/ijfs.2016.4763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Endometriosis - morphology, clinical presentations and molecular pathology. Agarwal N, Subramanian A. J Lab Physicians. 2010;2:1–9. doi: 10.4103/0974-2727.66699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Macer ML, Taylor HS. Obstet Gynecol Clin North Am. 2012;39:535–549. doi: 10.1016/j.ogc.2012.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Scar endometrioma following obstetric surgical incisions: retrospective study on 33 cases and review of the literature. Leite GK, Carvalho LF, Korkes H, Guazzelli TF, Kenj G, Viana Ade T. Sao Paulo Med J. 2009;127:270–277. doi: 10.1590/S1516-31802009000500005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Scar endometriosis-a sequel of caesarean section. Patil NJ, Kumar V, Gupta A. J Clin Diagn Res. 2014;8:0–10. doi: 10.7860/JCDR/2014/7554.4267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Endometriosis of the terminal ileum: a diagnostic dilemma. Karaman K, Pala EE, Bayol U, Akman O, Olmez M, Unluoglu S, Ozturk S. Case Rep Pathol. 2012;2012:742035. doi: 10.1155/2012/742035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Bladder endometriosis and endocervicosis: presentation of 2 cases with endoscopic management and review of literature. Pastor JF, Diego RB, Gómez MÁC, Díez ET, Flórez AF, Olmos GB, Baños JLG. Case Rep Urol. 2014;2014:296908. doi: 10.1155/2014/296908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Diagnosis and treatment of bladder endometriosis: state of the art. Maccagnano C, Pellucchi F, Rocchini L, et al. Urol Int. 2012;89:249–258. doi: 10.1159/000339519. [DOI] [PubMed] [Google Scholar]
- 94.Colonic endometriosis: dig deeper for diagnosis. Badipatla KR, Vupputuri A, Niazi M, Blaise MN, Nayudu SK. Gastroenterology Res. 2017;10:59–62. doi: 10.14740/gr760e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Comorbidity delays diagnosis and increases disability at diagnosis in MS. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Neurology. 2009;72:117–124. doi: 10.1212/01.wnl.0000333252.78173.5f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study. Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Br J Cancer. 2002;86:1034–1040. doi: 10.1038/sj.bjc.6600209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Delays in cancer diagnosis in underinsured young adults and older adolescents. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Oncologist. 2007;12:816–824. doi: 10.1634/theoncologist.12-7-816. [DOI] [PubMed] [Google Scholar]
- 98.Endometriosis: current concepts and therapy. Valle RF. Int J Gynaecol Obstet. 2002;78:107–119. doi: 10.1016/s0020-7292(02)00132-7. [DOI] [PubMed] [Google Scholar]
- 99.Treatment of urinary tract endometriosis. Gustilo-Ashby AM, Paraiso MF. J Minim Invasive Gynecol. 2006;13:559–565. doi: 10.1016/j.jmig.2006.07.012. [DOI] [PubMed] [Google Scholar]
- 100.Association of endometriosis with body size and figure. Hediger ML, Hartnett HJ, Louis GM. Fertil Steril. 2005;84:1366–1374. doi: 10.1016/j.fertnstert.2005.05.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Endometriosis and physical exercises: a systematic review. Bonocher CM, Montenegro ML, Rosa E Silva JC, Ferriani RA, Meola J. Reprod Biol Endocrinol. 2014;12:4. doi: 10.1186/1477-7827-12-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Who gets endometriosis? Kennedy S. Women’s Health Med. 2005;2:18–19. [Google Scholar]
- 103.24: Can Symptomatology Provide Clues to the Diagnosis of Endometriosis?: A National Case-control Study of 5,544 Women With Endometriosis. Ballard KD, Mangubat MC. J Minimally Invasive Gynecol. 2007;14 [Google Scholar]
- 104.Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Abbas S, Ihle P, Köster I, Schubert I. Eur J Obstet Gynecol Reprod Biol. 2012;160:79–83. doi: 10.1016/j.ejogrb.2011.09.041. [DOI] [PubMed] [Google Scholar]
- 105.Ovarian endometrioma in the adolescent: a plea for early-stage diagnosis and full surgical treatment. Gordts S, Puttemans P, Gordts S, Brosens I. Gynecol Surg. 2015;12:21–30. doi: 10.1007/s10397-014-0877-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Ovarian endometriomas in adolescents often represent active angiogenic disease requiring early diagnosis and careful management. Benagiano G, Bianchi P, Brosens I. Minerva Ginecol. 2017;69:100–107. doi: 10.23736/S0026-4784.16.03919-8. [DOI] [PubMed] [Google Scholar]
- 107.Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Suryawanshi S, Huang X, Elishaev E, et al. Clin Cancer Res. 2014;20:6163–6174. doi: 10.1158/1078-0432.CCR-14-1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Recurrence of ovarian endometrioma in adolescents after conservative, laparoscopic cyst enucleation. Lee SY, Kim ML, Seong SJ, Bae JW, Cho YJ. J Pediatr Adolesc Gynecol. 2017;30:228–233. doi: 10.1016/j.jpag.2015.11.001. [DOI] [PubMed] [Google Scholar]
- 109.Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Kitajima M, Defrère S, Dolmans MM, Colette S, Squifflet J, Van Langendonckt A, Donnez J. Fertil Steril. 2011;96:685–691. doi: 10.1016/j.fertnstert.2011.06.064. [DOI] [PubMed] [Google Scholar]
- 110.Ovarian endometriomas and oocyte quality: insights from in vitro fertilization cycles. Filippi F, Benaglia L, Paffoni A, Restelli L, Vercellini P, Somigliana E, Fedele L. Fertil Steril. 2014;101:988–993. doi: 10.1016/j.fertnstert.2014.01.008. [DOI] [PubMed] [Google Scholar]
- 111.Ovarian endometrioma - a possible finding in adolescent girls and young women: a mini-review. Gałczyński K, Jóźwik M, Lewkowicz D, Semczuk-Sikora A, Semczuk A. J Ovarian Res. 2019;12:104. doi: 10.1186/s13048-019-0582-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Mesonephroma: of ovary. Tumor of müllerian nature related to the endometrioid carcinoma. Scully RE, Barlow JF. Cancer. 1967;20:1405–1417. doi: 10.1002/1097-0142(196709)20:9<1405::aid-cncr2820200907>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
- 113.Abdominal wall endometriomas. Blanco RG, Parithivel VS, Shah AK, et al. Am J Surg. 2003;185:596–598. doi: 10.1016/s0002-9610(03)00072-2. [DOI] [PubMed] [Google Scholar]
- 114.Abdominal wall endometrioma; a 10-year experience and brief review of the literature. Bektaş H, Bilsel Y, Sari YS, et al. J Surg Res. 2010;164:0–81. doi: 10.1016/j.jss.2010.07.043. [DOI] [PubMed] [Google Scholar]
- 115.American College of Obstetricians and Gynecologists practice bulletins: an overview. Chauhan SP, Berghella V, Sanderson M, Magann EF, Morrison JC. Am J Obstet Gynecol. 2006;194:1564–1572. doi: 10.1016/j.ajog.2006.03.001. [DOI] [PubMed] [Google Scholar]
- 116.Cesarean scar endometriosis: an uncommon surgical complication on the rise? Case report and literature review. Khachani I, Filali Adib A, Bezad R. Case Rep Obstet Gynecol. 2017;2017:8062924. doi: 10.1155/2017/8062924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.L Mettler (ed): Manual for laparoscopic and hysteroscopic gynaecological surgery. Soyinka AS. Gynecol Surg. 2007;4:65. [Google Scholar]
- 118.Extragenital endometriosis. Veeraswamy A, Lewis M, Mann A, Kotikela S, Hajhosseini B, Nezhat C. Clin Obstet Gynecol. 2010;53:449–466. doi: 10.1097/GRF.0b013e3181e0ea6e. [DOI] [PubMed] [Google Scholar]
- 119.Urinary tract endometriosis. Kołodziej A, Krajewski W, Dołowy Ł, et al. Urol J. 2015;12:2213–2217. [PubMed] [Google Scholar]